Member Info for Toukankahmoon

30 odd dosed until then

McMuff

Look back at December meeting and tell me how many patients out of the 40 odd dosed up until then showed significant signs of efficacy. I think it was 6 we were given data for.

Bein

There will be no takeover because Al is a scientist and won’t risk losing control of his “baby”. Nothing is going to happen until efficacy proved at end of P1 around mid year

McMuff

Efficacy is all important otherwise it might as well be ribena. There is a line of thought that the AVA6000 may be flushing from the system too quickly to be the most efficacious. One reason for moving to a fortnightly dosing regime in current trial.

McMuff

Efficacy is all important otherwise it might as well be ribena. There is a line of thought that the AVA6000 may be flushing from the system too quickly to be the most efficacious. One reason for moving to a fortnightly dosing regime in current trial.

McMuff

I agree. That is safety.

Little reported so far on efficacy. It wasn’t an efficacy trial. It was safety

Be4c

It is safe enough to progress clinical trials. And it is efficacious on a statistical small number of patients hence the trial continues.

McMuffin

C7 data will only underline what we mostly already know/think it won’t move the SP. The pivotal inflection will be the publication of fortnightly trial data around mid year closely followed by some financial action. Al has more or less implied that.

When so many of your posts are really useful why post this stupid comment? Unless of course there is some basis in fact. Is there?

. . . .and the SP will continue to track sideways at roughly £1

Keep ramping in the face of adversity happy clappers. I think it’s

C. The trials continue and there is nothing newsworthy until at least mid-year when the fortnightly data will give investors confidence and the promise of AVA3996 will bring forth a licensing deal. Until then the risks are still too high.

Jeez if it’s that simples it’s a wonder that we aren’t using it to replace dox right now with no further trials . But it isn’t is it? And that’s why we are where we are.

Cj62

. . . enough to change your lifestyle if it all goes wrong

BTW I do think (and have said many times on here) that Avacta will be a good investment. But it’s going to be quiet until at least mid year. No great RNS next week or next month that is going to take the SP up to £20 overnight. Al has been predicting SP inflections for longer than I can remember. I suspect it won’t come now but I am expecting to make some good gains over next 5 years.

McMuffin

There is an alternative but I guess you are too in love to contemplate it. I hope you haven’t bet your shirt on this as so many rampers imply the have.

GLA

Tim

Why do you defend them. There was nothing about shorting Avacta on here. Just a genuine question by ATBD. But PL75 and Bein just couldn’t stop themselves hijacking things to take a pop at Icecool.

What is wrong with you guys?

And yet again the usual suspects hijack and ruin a thread asking a legitimate question just so they can have a slanging match.

After all ATBD I’m sure you agree, abusing eachother is far more useful than having a constructive debate.

CTFSO

What isa CLN? So are you saying that Avacta are not short of cash?

. . . should have added that I’d love to be wrong for the sake of a nagging wife.

While I’m on a roll : I sincerely hope there won’t be a takeover. I don’t want Avacta lost in a big pharmaceutical company where many other products can affect the SP and dividend. Also an offer might well not be solely for cash it could include shares in the buying company.

Hooray. Some good non partisan posts.

Wish it would stay that way.

Many on here quote Al on various topics. So :

1. There eill be no takeover - Al is a scientist, he will not risk losing control of his baby.

2. AVA3996 presents an excellent licensing opportunity

3. Nothing revolutionary will happen until the end of P1. Not next week or next month.

Knotagain

No. I like positive stuff. What I hate is continually putting the best positive twist on information that is far from clear(an Al speciality) and could equally be read negatively. And I’m obviously not alone.

McMuffin

That is the classic rampers conclusion because you cannot bear to contemplate the more alarming possibility.